SAPI Vision
To make innovative medicine accessible to patients in Singapore. We achieve this through a sustainable and valued partnership with healthcare professionals and providers, government and patient group stakeholders, and a reputation of consistent ethical behavior.
About SAPI
Our Association was founded on 26 May 1966. It was then known as the Pharmaceutical Trade Association.
On 19 December 1975, the Association’s name was changed to the Singapore Association of Pharmaceutical Industries (SAPI) so as to encompass a wider spectrum of pharmaceutical related businesses into the Association, namely the distributors, manufacturers, representative offices and affiliated companies.
In 2016, SAPI celebrated its 50th Anniversary; 50 years of contributing to the healthcare sector and community in many ways including enhancing quality of healthcare through innovative medicines and R&D, adding value to the economy through investment in biopharmaceutical manufacturing and clinical studies facilities and developing talents in the biopharmaceutical sector.
Our members are primarily research-based biopharmaceutical multinational companies with novel/ innovative products.
As a body, SAPI
- Promotes ethical practices
- High-standards of ethical practices
- Self-regulating through our members’ voluntary acceptance and adherence to the SAPI Code of Conduct
- Seeks collaborative dialogues
Promote the understanding of the value of innovative medicines, to extend and enhance human life, through effective dialogues with the government, healthcare professionals and other stakeholders.
SAPI Board of Directors
A Board of Directors comprising of 1 President, 2 Vice‑Presidents and 9 Directors, governs the Singapore Association of Pharmaceutical Industries. Board members are normally executive officers of member firms, who are elected by the association’s members at its general meetings.
The elected Board serves a two-year term from the date of its election.
Mr. How Ti-Hwei
President
Country President
AstraZeneca Singapore Pte Ltd
Ms Celine Ting
Vice-President
Managing Director
Eisai (Singapore) Pte Ltd
Mr Enver Erkan
Vice-President
Managing Director
Pfizer Pte Ltd
Mr Guillermo Frydman
Director
Managing Director
Janssen Pharmaceutical
Mr Ryan Harper
Director
General Manager
Roche Singapore Pte Ltd
Ms Tan Yan Ann
Director
Chief Executive
Zuellig Pharma Pte Ltd
Mr Reuben Ong
Director
Country Lead, Singapore
Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd.
Mr Vincent Ruland
Director
Country Division Head (Singapore, Malaysia & Brunei)
Bayer (SEA) Pte Ltd
Mr Robert Bowers
Director
General Manager
GlaxoSmithKline Pte Ltd
Ms Celine Landie
Director
Managing Director
Novartis (Singapore) Pte Ltd
Ms Quek Wee Ling
Director
Head of Sanofi Genzyme (Sin/Mal/Thai)
Sanofi-aventis Singapore Pte Ltd
Mr Ashish Pal
Director
Managing Director
MSD Pharma Pte Ltd
Membership
The Association’s membership structure comprises of Ordinary and Associate members.
Ordinary Member:
Any business entity involved directly in the marketing of pharmaceutical products in Singapore. Generally, these companies are research-based multinational companies involved in Research and Development of novel products, and registered to operate in Singapore.
Associate Member:
Any business entity registered in Singapore, which is engaged in the promotion and advertising of medicinal products, or in the market research, publication or other activities related to medicinal products.
ORDINARY MEMBERS
ASSOCIATE MEMBERS
Finance & Development / Supply Chain Committee
Ms Tan Yan Ann
Zuellig Pharma Pte Ltd
Ethics & Business Integrity Committee
Mr Reuben Ong
Takeda Pharmaceuticals (Asia Pacific) Pte Ltd
EBIC-Charter.pdf
Public Policy & Stakeholder Engagement Committee
Mr Enver Erkan
Pfizer Pte Ltd
PPC-Charter.pdf
VWG-Charter.pdf
Regulatory Affairs Committee
Ms Celine Ting
Eisai (Singapore) Pte Ltd
Ms Lily Lim
Senior Administration Officer
Ms Christina Teo
Executive Director
Ms May Wang
Accounts/Administration Officer
Contact: 6738 0966 (Telephone) 6738 0977 (Fax)
Email : admin@sapi.org.sg
APPLICATION FOR MEMBERSHIP WITH SAPI
Information on how to join SAPI membership:
We have TWO categories of membership:
- ORDINARY MEMBER:
This category is restricted to pharmaceutical companies involved directly in the marketing of pharmaceutical products in Singapore. Generally, these companies are research-based multinational companies involved in Research and Development of novel products, and registered to operate in Singapore
- ASSOCIATE MEMBER:
This category is open to any entity registered in Singapore, which is engaged in the promotion and advertising of medicinal products, or in the market research, publication or other activities related to medicinal products.
The application for membership shall be considered and approved by the SAPI Board of Directors. If approved, and upon payment of the prescribed entrance and membership fees, shall thereupon become a Member and shall enjoy all the privileges of the Association, except that Associate Members:
- shall not Propose or Second any Member for election to the Board,
- shall not vote at any General election
- shall not be eligible to be a Board Director
Please email SAPI secretariat for more information and application forms at admin@sapi.org.sg
Download PDF
53rd Annual General Meeting (Members Only Event)
Call us to register at +65 6738 0966 or log in to register online.